Ennature Bio Pharma
ENNATURE
Pharma₹208.85
Price as of 13 Nov 2026, 9:18 pm IST
Market cap ₹467 Cr
- P/E
- —
- Day range
- ₹195.30 – ₹214.70
- 52-week range
- ₹190.00 – ₹264.90
- Volume
- 35,659
- Open
- ₹203.00
- Prev close
- ₹204.55
No red flags in exchange filings: no rising pledge, promoter selling, surveillance or critical filing on record.
ENNATURE in NSE indices and F&O
Peer comparison
All 68 in Pharma| Company | M-cap | P/E | P/B | ROE | ROCE | OPM | D/E | Sales YoY |
|---|---|---|---|---|---|---|---|---|
| Sun PharmaSUNPHARMA | ₹4.51 L Cr | 41.14 | 5.11 | 14.8% | 21.0% | 29.0% | 0.04 | +11.9% |
| Divi's LaboratoriesDIVISLAB | ₹3.04 L Cr | 90.29 | 16.94 | 16.2% | 22.0% | 43.0% | 0.00 | +35.4% |
| Torrent PharmaTORNTPHARM | ₹1.78 L Cr | 78.89 | 9.86 | 26.8% | 15.0% | 33.0% | 0.77 | +50.8% |
| Laurus LabsLAURUSLABS | ₹1.31 L Cr | 97.82 | 21.91 | 18.2% | 18.0% | 34.0% | 0.43 | +33.5% |
| Apollo HospitalsAPOLLOHOSP | ₹1.23 L Cr | 54.52 | 11.54 | 22.6% | 17.0% | 16.0% | 0.77 | +23.0% |
| Zydus LifesciencesZYDUSLIFE | ₹1.19 L Cr | 28.43 | 4.30 | 20.1% | 21.0% | 24.0% | 0.50 | +29.2% |
| Dr. Reddy's LabsDRREDDY | ₹1.15 L Cr | 41.08 | 2.98 | 11.6% | 13.0% | 20.0% | 0.19 | -1.5% |
| Ennature Bio PharmaENNATURE | ₹467 Cr | — | — | — | — | — | — | — |
| Sector median | ₹24,613 Cr | 44.15 | 5.47 | 15.1% | 17.0% | 24.0% | 0.17 | +20.8% |
Sector as classified in the tracked universe; medians use every tracked Pharma company, and P/E only profitable ones. Tinted figures beat the median.
Latest news
Updated 4h agoHeadlines about Ennature Bio Pharma from the last two weeks in the financial press. Stories belong to their publishers; Rajat Finance does not endorse them.
Financials not yet synced
This company is tracked, but its filings have not been processed yet. Results appear here once the next sync reaches it.
Corporate actions
No dividends, splits or bonuses recorded for this company yet.
FAQ
Ennature Bio Pharma: common questions
Answered from the figures on this page.
Ennature Bio Pharma last traded at ₹208.85 (NSE, as of 13 Nov 2026). The last session moved it up 2.10%.
Ennature Bio Pharma is valued at about ₹467 crore (NSE, as of 13 Nov 2026).
Ennature Bio Pharma has traded between ₹190.00 and ₹264.90 over the past 52 weeks, to 13 Nov 2026. It is currently 25% of the way up that range.
Ennature Bio Pharma (ENNATURE) is classified under Pharma on this site's screener.